Jilin Province Huinan Changlong Bio-pharmacy Co Ltd operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Jilin Province Huinan Changlong Bio-pharmacy Co Ltd with three other
companies in this sector in China:
Shanghai Fudan Forward S&T Co Ltd
sales of 670.57 million Chinese Renmimbi [US$99.31 million]
of which 56%
Ginwa Enterprise Group Inc.
(666.08 million Chinese Renmimbi [US$98.65 million]
of which 73%
was Pharmaceutical Industry), and
Zhejiang Starry Pharmaceutical Co Ltd
(672.75 million Chinese Renmimbi [US$99.63 million]
of which 99%
was Pharmaceuticals Industry).
Jilin Province Huinan Changlong Bio-pharmacy Co Ltd reported sales of 654.12 million Chinese Renmimbi (US$96.88 million)
December of 2016.
increase of 21.3%
versus 2015, when the company's sales were 539.13 million Chinese Renmimbi.